160 related articles for article (PubMed ID: 38543175)
21. Discovery of a potent histone deacetylase (HDAC) 3/6 selective dual inhibitor.
Soumyanarayanan U; Ramanujulu PM; Mustafa N; Haider S; Fang Nee AH; Tong JX; Tan KSW; Chng WJ; Dymock BW
Eur J Med Chem; 2019 Dec; 184():111755. PubMed ID: 31627059
[TBL] [Abstract][Full Text] [Related]
22. Novel cyclic C
Huber I; Pandur E; Sipos K; Barna L; Harazin A; Deli MA; Tyukodi L; Gulyás-Fekete G; Kulcsár G; Rozmer Z
Eur J Pharm Sci; 2022 Jun; 173():106184. PubMed ID: 35413433
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, in vitro and structural aspects of cap substituted Suberoylanilide hydroxamic acid analogs as potential inducers of apoptosis in Glioblastoma cancer cells via HDAC /microRNA regulation.
Mekala JR; Ramalingam PS; Mathavan S; Yamajala RBRD; Moparthi NR; Kurappalli RK; Manyam RR
Chem Biol Interact; 2022 Apr; 357():109876. PubMed ID: 35283086
[TBL] [Abstract][Full Text] [Related]
24. β-Carboline tethered cinnamoyl 2-aminobenzamides as class I selective HDAC inhibitors: Design, synthesis, biological activities and modelling studies.
Namballa HK; Anchi P; Lakshmi Manasa K; Soni JP; Godugu C; Shankaraiah N; Kamal A
Bioorg Chem; 2021 Dec; 117():105461. PubMed ID: 34753060
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of trimetrexate cytotoxicity in vitro and in vivo by carboxypeptidase G2.
Romanini A; Sobrero AF; Chou TC; Sherwood RF; Bertino JR
Cancer Res; 1989 Nov; 49(21):6019-23. PubMed ID: 2529027
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis, and biological evaluation of novel dual inhibitors targeting lysine specific demethylase 1 (LSD1) and histone deacetylases (HDAC) for treatment of gastric cancer.
Duan YC; Jin LF; Ren HM; Zhang SJ; Liu YJ; Xu YT; He ZH; Song Y; Yuan H; Chen SH; Guan YY
Eur J Med Chem; 2021 Aug; 220():113453. PubMed ID: 33957387
[TBL] [Abstract][Full Text] [Related]
27. Chimeric HDAC and the cytoskeleton inhibitor broxbam as a novel therapeutic strategy for liver cancer.
Bär SI; Dittmer A; Nitzsche B; Ter-Avetisyan G; Fähling M; Klefenz A; Kaps L; Biersack B; Schobert R; Höpfner M
Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35485292
[TBL] [Abstract][Full Text] [Related]
28. Antiproliferative and cytotoxic effects of sesquiterpene lactones isolated from
Kovács B; Szemerédi N; Kúsz N; Kiss T; Csupor-Löffler B; Tsai YC; Rácz B; Spengler G; Csupor D
Pharm Biol; 2022 Dec; 60(1):1511-1519. PubMed ID: 35952383
[TBL] [Abstract][Full Text] [Related]
29. Pre-clinical evaluation of LASSBio-1491: From in vitro pharmacokinetic study to in vivo leishmanicidal activity.
de Queiroz AC; Barbosa G; de Oliveira VRT; de Mattos Alves H; Alves MA; Carregaro V; Santana da Silva J; Barreiro EJ; Alexandre-Moreira MS; Lima LM
PLoS One; 2022; 17(6):e0269447. PubMed ID: 35666748
[TBL] [Abstract][Full Text] [Related]
30. In Vitro, In Vivo and In Silico Effectiveness of LASSBio-1386, an
Silva DKC; Teixeira JS; Moreira DRM; da Silva TF; Barreiro EJL; de Freitas HF; Pita SSDR; Teles ALB; Guimarães ET; Soares MBP
Front Pharmacol; 2020; 11():590544. PubMed ID: 33390966
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of a selective HDAC6 inhibitor active in neuroblasts.
Zwick V; Simões-Pires CA; Nurisso A; Petit C; Dos Santos Passos C; Randazzo GM; Martinet N; Bertrand P; Cuendet M
Bioorg Med Chem Lett; 2016 Oct; 26(20):4955-4959. PubMed ID: 27650925
[TBL] [Abstract][Full Text] [Related]
32. Etoposide-induced cytotoxicity in two human T-cell leukemic lines: delayed loss of membrane permeability rather than DNA fragmentation as an indicator of programmed cell death.
Catchpoole DR; Stewart BW
Cancer Res; 1993 Sep; 53(18):4287-96. PubMed ID: 8364925
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxicity of three naturally occurring flavonoid derived compounds (artocarpesin, cycloartocarpesin and isobavachalcone) towards multi-factorial drug-resistant cancer cells.
Kuete V; Mbaveng AT; Zeino M; Fozing CD; Ngameni B; Kapche GD; Ngadjui BT; Efferth T
Phytomedicine; 2015 Nov; 22(12):1096-102. PubMed ID: 26547532
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxicity of epunctanone and four other phytochemicals isolated from the medicinal plants Garcinia epunctata and Ptycholobium contortum towards multi-factorial drug resistant cancer cells.
Mbaveng AT; Fotso GW; Ngnintedo D; Kuete V; Ngadjui BT; Keumedjio F; Andrae-Marobela K; Efferth T
Phytomedicine; 2018 Sep; 48():112-119. PubMed ID: 30195869
[TBL] [Abstract][Full Text] [Related]
35. Design, Synthesis, and Biological Evaluation of Quinazolin-4-one-Based Hydroxamic Acids as Dual PI3K/HDAC Inhibitors.
Thakur A; Tawa GJ; Henderson MJ; Danchik C; Liu S; Shah P; Wang AQ; Dunn G; Kabir M; Padilha EC; Xu X; Simeonov A; Kharbanda S; Stone R; Grewal G
J Med Chem; 2020 Apr; 63(8):4256-4292. PubMed ID: 32212730
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
Bakr RB; Mehany ABM; Abdellatif KRA
Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
[TBL] [Abstract][Full Text] [Related]
37. The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer.
Ma L; Bian X; Lin W
J Exp Clin Cancer Res; 2020 Oct; 39(1):219. PubMed ID: 33069237
[TBL] [Abstract][Full Text] [Related]
38. Image-guided synthesis reveals potent blood-brain barrier permeable histone deacetylase inhibitors.
Seo YJ; Kang Y; Muench L; Reid A; Caesar S; Jean L; Wagner F; Holson E; Haggarty SJ; Weiss P; King P; Carter P; Volkow ND; Fowler JS; Hooker JM; Kim SW
ACS Chem Neurosci; 2014 Jul; 5(7):588-96. PubMed ID: 24780082
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxicity of the methanol extracts and compounds of Brucea antidysenterica (Simaroubaceae) towards multifactorial drug-resistant human cancer cell lines.
Youmbi LM; Makong YSD; Mbaveng AT; Tankeo SB; Fotso GW; Ndjakou BL; Wansi JD; Beng VP; Sewald N; Ngadjui BT; Efferth T; Kuete V
BMC Complement Med Ther; 2023 Feb; 23(1):48. PubMed ID: 36793009
[TBL] [Abstract][Full Text] [Related]
40. LPIN1 downregulation enhances anticancer activity of the novel HDAC/PI3K dual inhibitor FK-A11.
Imai H; Saijo K; Chikamatsu S; Kawamura Y; Ishioka C
Cancer Sci; 2021 Feb; 112(2):792-802. PubMed ID: 33274548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
